The CHEK2(*)1100delC mutation has no major contribution in oesophageal carcinogenesis.
D000230:Adenocarcinoma / Q000235:genetics* / Q000503:physiopathology*; D001471:Barrett Esophagus / Q000150:complications / Q000235:genetics / Q000473:pathology; D002294:Carcinoma, Squamous Cell / Q000235:genetics* / Q000503:physiopathology*; D016022:Case-Control Studies; D002471:Cell Transformation, Neoplastic; D064447:Checkpoint Kinase 2; D015331:Cohort Studies; D004252:DNA Mutational Analysis; D004261:DNA Replication; D004938:Esophageal Neoplasms / Q000235:genetics* / Q000503:physiopathology*; D016368:Frameshift Mutation; D016147:Genes, Tumor Suppressor; D006801:Humans; D017346:Protein Serine-Threonine Kinases / Q000235:genetics*
D064447:Checkpoint Kinase 2; C578634:CHEK2 protein, human; D017346:Protein Serine-Threonine Kinases